News

LGI produces electricity from landfill gas and boasts a significant growth trajectory set to generate material revenues and ...
In a report released yesterday, Brian McNamara from Canaccord Genuity reiterated a Buy rating on EZCORP (EZPW – Research Report), with a price ...
In a report released yesterday, Caitlin Cronin from Canaccord Genuity reiterated a Buy rating on TELA Bio (TELA – Research Report), with a ...
Fintel reports that on April 1, 2025, CANACCORD GENUITY downgraded their outlook for Converge Technology Solutions ...
Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.75, a high estimate of ...
As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, ...
BCE (TSE:BCE – Free Report) (NYSE:BCE) had its target price decreased by Canaccord Genuity Group from C$33.50 to C$31.50 in a ...
Canaccord Genuity Group set a C$12.50 target price on Cipher Pharmaceuticals (TSE:CPH – Free Report) (NASDAQ:CPHR) in a research note released on Monday morning,BayStreet.CA reports. The brokerage ...
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic ...
China’s restrictions on exports of medium and heavy rare earths will disrupt global supply chains, opening the door for ...
CBLL's lockup expiration on April 9th could impact share prices. Click here to find out why CBLL stock is a Sell.